BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3723140)

  • 1. Responses of hairy cell leukemia cells to a recombinant alpha-2 interferon in vitro and in vivo: correlation between formation of tubuloreticular structures and clinical parameters.
    Hiraoka A; Golomb HM
    J Biol Response Mod; 1986 Jun; 5(3):270-81. PubMed ID: 3723140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
    Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
    Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro response of cells from three patients with hairy cell leukemia to a recombinant leukocyte interferon.
    Hiraoka A; Rosner MC; Golomb HM
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 49(1):73-82. PubMed ID: 2862737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
    Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic and immunologic changes in hairy cell leukemia patients treated with alpha interferon.
    Turhan AG; Eaves CJ; Connors JM; Eaves AC; Karim KA; Silver KB
    J Biol Regul Homeost Agents; 1988; 2(4):157-65. PubMed ID: 2907963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hairy cell leukemia with ultrastructural finding of 'tubuloreticular inclusions' in hairy cells: a possible marker of a virus-induced disease?
    Mantovani G; Santa Cruz G; Piso A; Arangino V; Balestrieri A; Del Giacco GS
    J Submicrosc Cytol; 1986 Jul; 18(3):617-24. PubMed ID: 3746974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
    Vedantham S; Gamliel H; Golomb HM
    Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy-cell leukemia and alpha-interferon treatment: long-term responders.
    Zinzani PL; Lauria F; Salvucci M; Rondelli D; Raspadori D; Bendandi M; Magagnoli M; Tura S
    Haematologica; 1997; 82(2):152-5. PubMed ID: 9175317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction of proteins by alpha-interferon in hairy cell leukemia.
    Samuels BL; Golomb HM; Brownstein BH
    Cancer Res; 1986 Aug; 46(8):4151-5. PubMed ID: 3731082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
    Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
    J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different proteins are induced by alpha- and gamma-interferon in hairy cell leukemia.
    Samuels BL; Golomb HM; Brownstein BH
    J Biol Response Mod; 1987 Jun; 6(3):268-74. PubMed ID: 3110377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate production of hematopoietic growth factors in hairy cell leukemia: up-regulation of interleukin 6 by recombinant IFN-alpha in vitro.
    Schwarzmeier JD; Hilgarth M; Nguyen ST; Shehata M; Gruber G; Spittler A; Willheim M; Boltz-Nitulescu G; Höcker P; Berger R
    Cancer Res; 1996 Oct; 56(20):4679-85. PubMed ID: 8840984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced surface alterations in hairy cells. A review.
    Gamliel H; Gurfel D; Wu SH; Golomb HM
    Scanning Microsc; 1988 Mar; 2(1):485-92. PubMed ID: 3368772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.
    Lepe-Zuniga JL; Quesada JR; Baron S; Reuben J; Gutterman JU
    Hematol Pathol; 1987; 1(3):157-65. PubMed ID: 3150846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The therapeutic effect of interferon-alpha exemplified by hairy cell leukemia].
    Schwarzmeier JD
    Wien Med Wochenschr; 1993; 143(16-17):412-5. PubMed ID: 8273363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of interferons in hairy cell leukemia.
    Samuels BL; Rosner MC; Giometti CS; Golomb HM; Brownstein BH
    Leukemia; 1987 Apr; 1(4):365-9. PubMed ID: 2444830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement with interferon-alpha therapy and splenectomy in hairy cell leukemia of European-American type].
    Yasuyama M; Kawauchi K; Sugiyama H; Mori H; Enomoto Y; Watanabe Y; Machii T; Kitani T
    Rinsho Ketsueki; 1992 Mar; 33(3):365-70. PubMed ID: 1578641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.